Therapeutic area

Skin and subcutaneous tissue disorders – page 30

844 clinical trials
268 recruiting
353 conditions
25 countries

Clinical trials in Skin and subcutaneous tissue disorders

844 trials across Europe, recruiting first

Click a country to filter the trials

Quick filters

844 clinical trials

Systemic lupus erythematosus+6

Not yet recruiting

Study of RSV vaccines Arexvy and Abrysvo in patients with inflammatory rheumatic diseases receiving anti-rheumatic treatments

Registered drugNo placebo

Study of RSV vaccines Arexvy and Abrysvo in patients with inflammatory rheumatic diseases receiving anti-rheumatic treatments

Registered drugNo placebo

Sweden

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Respiratory Syncytial Virus, Glycoprotein F, Recombinant, Stabilised In The Pre-Fusion Conformation, Adjuvanted With As01E
Sponsor:Region Skane

Contact Research Centre

Malignant melanoma

Not yet recruiting

Long-term follow-up study of fianlimab and cemiplimab combination treatment in adult patients with melanoma

Registered drugNo placebo

Long-term follow-up study of fianlimab and cemiplimab combination treatment in adult patients with melanoma

Registered drugNo placebo

Ireland

Participants:18–64 years · 65+ years
Substances:Cemiplimab
Sponsor:Regeneron Pharmaceuticals Inc.

Contact Research Centre

Evaluating Safety and Effectiveness of Combining Biologic Medications for Patients with Rheumatoid Arthritis and Psoriatic Arthritis ## Human: Give a detailed summary of a clinical trial for patients: 1.

Registered drugNo placebo

Evaluating Safety and Effectiveness of Combining Biologic Medications for Patients with Rheumatoid Arthritis and Psoriatic Arthritis ## Human: Give a detailed summary of a clinical trial for patients: 1.

Registered drugNo placebo

Spain

Participants:18–64 years · 65+ years
Substances:Tocilizumab
Sponsor:Cardiff University

Contact Research Centre

Hidradenitis

Not yet recruiting

Study on Fecal Microbiota Transplantation and Amoxicillin-Clavulanic Acid for Patients with Moderate to Severe Hidradenitis Suppurativa

InvestigationalNo placebo

Study on Fecal Microbiota Transplantation and Amoxicillin-Clavulanic Acid for Patients with Moderate to Severe Hidradenitis Suppurativa

InvestigationalNo placebo

France

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Allogeneic Faecal Microbiota
Sponsor:University Hospital Of Clermont-Ferrand

Contact Research Centre

Malignant melanoma stage II

Not yet recruiting

Study of Pembrolizumab for Patients with Stage IIb/c Melanoma

Registered drug

Study of Pembrolizumab for Patients with Stage IIb/c Melanoma

Registered drug

Denmark

Participants:18–64 years · 65+ years
Substances:Pembrolizumab
Sponsor:Vaestra Goetalandsregionen

Contact Research Centre

Eczema+1

Not yet recruiting

Study on the Safety and Effectiveness of Metal Panel Allergens for Diagnosing Allergic Contact Dermatitis and Eczema in Patients

Registered drugNo placebo

Study on the Safety and Effectiveness of Metal Panel Allergens for Diagnosing Allergic Contact Dermatitis and Eczema in Patients

Registered drugNo placebo

Germany

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:ZINC CHLORIDE
Sponsor:Smarthealth Inc.

Contact Research Centre

Varicella

Not yet recruiting

Study on the Immune Response and Safety of a Second Dose of Investigational Varicella Vaccine (GSKVX000000025896) Compared to Varicella Virus Oka/Merck Strain in Healthy Children

Registered drugNo placebo